Report cover image

Cardiovascular Pacing and ICD Leads Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022

Publisher GlobalData
Published Mar 17, 2022
Length 60 Pages
SKU # GBDT17166084

Description

Cardiovascular Pacing and ICD Leads Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022

Summary

GlobalData's Medical Devices sector report, “Cardiovascular Pacing and ICD Leads Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 provides comprehensive information about the Cardiovascular Pacing and ICD Leads pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiovascular Pacing and ICD Leads under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Pacing and ICD Leads and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage- Identify and understand important and diverse types of Cardiovascular Pacing and ICD Leads under development- Develop market-entry and market expansion strategies- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

60 Pages
  • About GlobalData
    • Cardiovascular Pacing and ICD Leads Overview
    • Cardiovascular Pacing and ICD Leads - Pipeline Products by Stage of Development
    • Cardiovascular Pacing and ICD Leads - Pipeline Products by Territory
    • Cardiovascular Pacing and ICD Leads - Pipeline Products by Regulatory Path
    • Cardiovascular Pacing and ICD Leads - Pipeline Products by Estimated Approval Date
    • Cardiovascular Pacing and ICD Leads - Ongoing Clinical Trials
    • Cardiovascular Pacing and ICD Leads Companies - Pipeline Products by Stage of Development
    • Cardiovascular Pacing and ICD Leads – Companies Pipeline Products by Stage of Development
    • APT Medical Inc Company Overview
    • Biotronik SE & Co KG Company Overview
    • Boston Scientific Corp Company Overview
    • Mayo Clinic Company Overview
    • Medtronic Inc Company Overview
    • MicroPort CRM SA Company Overview
    • MicroPort Scientific Corp Company Overview
    • St. Jude Medical LLC Company Overview
    • Teleflex Inc Company Overview
    • Feb 15, 2022: T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
    • Jan 11, 2022: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results
    • Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
    • Nov 18, 2021: MicroPort RehabTech TherMotion Cryo-Thermo compression device approved for marketing in China
    • Nov 12, 2021: Shree Pacetronix Announces Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2021
    • Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
    • Nov 04, 2021: T2 Biosystems Hires Industry Veteran Brett Giffin as Chief Commercial Officer
    • Nov 03, 2021: LivaNova Reports Third Quarter 2021 Results
    • Oct 28, 2021: Integer Holdings Reports Third Quarter 2021 Results
    • Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
    • Oct 19, 2021: T2 Biosystems Appoints Laura Adams to Its Board of Directors
    • Oct 07, 2021: Construction begins on 280,000-square-meter MicroPort MegaFactory and global medical experience center
    • Sep 28, 2021: Integer Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021
    • Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
    • Aug 05, 2021: T2 Biosystems Announces Second Quarter 2021 Financial Results
    • Jul 28, 2021: LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer
    • Jul 15, 2021: ClearPoint Neuro Announces Appointment of Lynnette C. Fallon to Board of Directors
    • Jun 21, 2021: T2 Biosystems to Participate at Clinical Conferences in June and July 2021
    • Jun 21, 2021: Integer Schedules Second Quarter 2021 Earnings Release and Conference Call for July 29, 2021
    • May 25, 2021: T2 Biosystems Reminds Stockholders to Vote at the Upcoming Annual Meeting
    • May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
    • May 17, 2021: MicroPort Orthopedics holds joint workshop on joint surgery with China-Japan Friendship Hospital
    • Apr 29, 2021: Integer Holdings Reports First Quarter 2021 Results
    • Apr 01, 2021: Integer Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us